Search - tctmd.com

Displaying 41 - 60 of 175

Sort: Relevancy | Date

Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements

News Conference News EuroPCR 2019

Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements

May 16, 2019

News Industry News

FDA Approves Impella 5.0 and Impella LD Extended Duration of Use to 14 Days for Cardiogenic Shock Derived from AMI or Cardiomyopathy

May 13, 2019

Twitter Takes on the Times of India, but the Question Persists: Is Foregoing a Stent an Option?

News Features

Twitter Takes on the Times of India, but the Question Persists: Is Foregoing a Stent an Option?

April 30, 2019

STEMI Care and Outcomes Still Affected by Socioeconomic Status, Insurance

News Daily News

STEMI Care and Outcomes Still Affected by Socioeconomic Status, Insurance

Yael L. Maxwell

January 09, 2019

Many PCI Patients Treated in China Have No Angina Symptoms

News Daily News

Many PCI Patients Treated in China Have No Angina Symptoms

December 20, 2018

Gender Gap Still Wide Open as US Data Show Men Have Consistently Better PCI Outcomes

News Daily News

Gender Gap Still Wide Open as US Data Show Men Have Consistently Better PCI Outcomes

September 14, 2018

BASKET-SMALL 2: Drug-Coated Balloon Fares Well Against DES for De Novo Small-Vessel Disease

News Conference News ESC 2018

BASKET-SMALL 2: Drug-Coated Balloon Fares Well Against DES for De Novo Small-Vessel Disease

August 28, 2018

“Transient” STEMI Patients Can Be Immediately Treated or Safely Deferred to Next Day

News Conference News EuroPCR 2018

‘Transient’ STEMI Patients Can Be Immediately Treated or Safely Deferred to Next Day

Michael O'Riordan

May 24, 2018

Impella Use in Acute MI and Cardiogenic Shock: Clues From US Registry Data

News Daily News

Impella Use in Acute MI and Cardiogenic Shock: Clues From US Registry Data

April 12, 2018

Varenicline Boosts Long-term Quit Rate in Post-ACS Smokers: EVITA

News Daily News

Varenicline Boosts Long-term Quit Rate in Post-ACS Smokers: EVITA

March 26, 2018

Time to Shine: ‘Historic’ All-Female Team Takes Over Live Case at CRT 2018

News Conference News CRT 2018

Time to Shine: ‘Historic’ All-Female Team Takes Over Live Case at CRT 2018

Michael O'Riordan

March 06, 2018

Coronary Embolism in STEMI Is Rare but Warrants a Unique Approach

News Daily News

Coronary Embolism in STEMI Is Rare but Warrants a Unique Approach

January 11, 2018

Trajectory Unknown: How ORBITA Lands in Clinical Practice Still Up for Debate

News Features

Trajectory Unknown: How ORBITA Lands in Clinical Practice Still Up for Debate

Michael O'Riordan

November 27, 2017

Live From Denver: TCT 2017, Day One

News Conference News TCT 2017

Live From Denver: TCT 2017, Day One

October 30, 2017

WhatsApp Enables Swift Diagnosis of STEMI and Cath Lab Activation

News Daily News

WhatsApp Enables Swift Diagnosis of STEMI and Cath Lab Activation

Yael L. Maxwell

October 27, 2017

CHANGE DAPT: Study Contests Benefit of Ticagrelor Over Clopidogrel After PCI in ACS

News Conference News ESC 2017

CHANGE DAPT: Study Contests Benefit of Ticagrelor Over Clopidogrel After PCI in ACS

August 30, 2017

P2Y12 Inhibitor Pretreatment Questioned in STEMI

News Conference News ESC 2017

P2Y12 Inhibitor Pretreatment Questioned in STEMI

August 29, 2017

Technique for Diluting the Blood During Primary PCI to Prevent Reperfusion Injury Seems Safe, Feasible

News Daily News

Technique for Diluting the Blood During Primary PCI to Prevent Reperfusion Injury Seems Safe, Feasible

July 04, 2017

Almost Half of US Operators Do Under 50 PCIs Per Year: Does It Matter?

News Daily News

Almost Half of US Operators Do Under 50 PCIs Per Year: Does It Matter?

June 15, 2017

Cardiogenic Shock Remains a Deadly Complication of Acute MI No Matter When It Develops

News Daily News

Cardiogenic Shock Remains a Deadly Complication of Acute MI No Matter When It Develops

June 09, 2017

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.